Canopy Growth (CGC) Enterprise Value (2017 - 2026)
Canopy Growth (CGC) posted Enterprise Value of -$265.9 million for Q1 2026, down 15.96% sequentially from -$229.3 million in Q4 2025, and down 190.25% YoY from $294.7 million in Q1 2025.
Canopy Growth (CGC) Enterprise Value (2017 - 2026) Analysis & Trends
Canopy Growth has reported Enterprise Value for 10 years, with the latest figure at -$265.9 million in Q1 2026.
- Quarterly Enterprise Value fell 190.25% year-over-year to -$265.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$265.9 million (down 190.25% YoY) and the FY2026 annual result came in at -$265.9 million, down 190.25% from the prior year.
- Enterprise Value retreated to -$265.9 million in Q1 2026 per CGC's latest filing, from -$229.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$89.5 million in Q4 2024 and troughed at -$1.1 billion in Q1 2022.
- A 5-year average of -$347.9 million and a median of -$187.1 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value jumped 78.42% in 2023, then slumped 190.25% in 2026.
- Over 5 years, Enterprise Value stood at -$580.7 million in 2022, then jumped by 76.47% to -$136.7 million in 2023, then soared by 34.53% to -$89.5 million in 2024, then plunged by 156.33% to -$229.3 million in 2025, then decreased by 15.96% to -$265.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$265.9 million, -$229.3 million, and -$94.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -247.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -247.01 Mn |
| Mar 31, 2026 | -265.93 Mn |
| Dec 31, 2025 | -229.33 Mn |
| Sep 30, 2025 | -94.07 Mn |
| Jun 30, 2025 | -95.29 Mn |
| Mar 31, 2025 | -91.62 Mn |
| Dec 31, 2024 | -89.47 Mn |
| Sep 30, 2024 | -172.93 Mn |
| Jun 30, 2024 | -146.12 Mn |
| Mar 31, 2024 | -131.70 Mn |
| Dec 31, 2023 | -136.65 Mn |
| Sep 30, 2023 | -187.10 Mn |
| Jun 30, 2023 | -402.62 Mn |
| Mar 31, 2023 | -412.07 Mn |
| Dec 31, 2022 | -580.71 Mn |
| Sep 30, 2022 | -866.99 Mn |
| Jun 30, 2022 | -932.55 Mn |
| Mar 31, 2022 | -1.08 Bn |
| Dec 31, 2021 | -1.13 Bn |
| Sep 30, 2021 | -596.16 Mn |